Buy Generic Eszopiclone Online
|
|
Generic Eszopiclone 1mg
Package | Price | Per Pill | Shipping | Order | |
1mg x 50 pills | CA $68.81 | CA $1.37 | Add to Cart | ||
1mg x 100 pills | CA $112.13 | CA $1.12 | Add to Cart | ||
1mg x 150 pills | CA $129.03 | CA $0.86 | Add to Cart |
Generic Eszopiclone 2mg
Package | Price | Per Pill | Shipping | Order | |
2mg x 100 pills | CA $84.48 | CA $0.84 | Add to Cart | ||
2mg x 150 pills | CA $108.30 | CA $0.72 | Add to Cart |
Generic Eszopiclone 3mg
Package | Price | Per Pill | Shipping | Order | |
3mg x 150 pills | CA $69.12 | CA $0.46 | Add to Cart |
Generic Eszopiclone Information
Introduction
Eszopiclone is a hypnotic medication used primarily to treat insomnia in adult patients. It belongs to the class of non‑benzodiazepine sedative‑hypnotics, often grouped under “sleeping aids” and “general health” therapeutics. In the United Kingdom, eszopiclone is not marketed as a licensed product but can be imported for personal use under the supervision of a qualified prescriber. The active compound, eszopiclone, binds selectively to the GABA‑A receptor complex, facilitating sleep initiation and maintenance without the muscle‑relaxant properties of traditional benzodiazepines. The medication is also investigated for off‑label uses such as circadian‑rhythm disorders, although these indications remain unapproved in the UK.
What is Eszopiclone?
Eszopiclone is the generic version of the brand‑name product Lunesta, which was developed and first marketed by Sunovion Pharmaceuticals (formerly Sepracor). Both formulations contain the same active compound, eszopiclone, and are chemically identical. Our online pharmacy provides this generic alternative as a cost‑effective treatment option for patients who require a reliable sleep aid and who may face limited access to the branded product.
The medication is classified as a non‑benzodiazepine hypnotic, also known as a “Z‑drug.” It is formulated as an oral tablet containing the active ingredient eszopiclone together with inert excipients that aid tablet integrity and dissolution.
Key points:
- Active compound: Eszopiclone (C₁₇H₁₇ClN₄O₃).
- Manufacturer: Originally Sunovion Pharmaceuticals; generic versions are supplied by GMP‑certified overseas manufacturers.
- Therapeutic group: Sleeping aids, general health.
How Eszopiclone Works
Eszopiclone binds to a distinct site on the α1 subunit of the GABA‑A receptor complex, enhancing the inhibitory action of the neurotransmitter gamma‑aminobutyric acid (GABA). This allosteric modulation increases chloride ion influx, hyperpolarising neuronal membranes and reducing neuronal excitability. The result is a dose‑dependent promotion of sleep onset and longer sleep duration.
Pharmacokinetic characteristics relevant to clinical use:
- Onset of action: 30–45 minutes after oral ingestion, aligning with typical bedtime dosing.
- Half‑life: Approximately 6 hours in healthy adults; prolonged in the elderly and in patients with hepatic impairment.
- Metabolism: Primarily hepatic via CYP3A4 and CYP2E1 pathways; metabolites are inactive and excreted renally.
These properties allow a single nightly dose to produce sustained hypnotic effect throughout the primary sleep period while minimising next‑day residual sedation in most patients.
Conditions Treated with Eszopiclone
Approved indication (UK) | Clinical relevance |
---|---|
Primary insomnia (difficulty initiating or maintaining sleep) | Insomnia affects an estimated 10 % of UK adults, contributing to reduced daytime productivity and increased accident risk. |
Short‑term sleep disruption (e.g., after shift work or jet lag) – off‑label | Provides rapid onset of sleep without the dependence risk associated with older hypnotics. |
Eszopiclone is favoured for patients who have not responded adequately to first‑line non‑pharmacologic sleep hygiene measures. Its prolonged half‑life relative to older Z‑drugs (e.g., zolpidem) offers benefit for maintaining sleep throughout the night, an important consideration for individuals with fragmented sleep patterns.
Who is Eszopiclone For?
Suitable patient populations include:
- Adults (≥18 years) with diagnosed chronic insomnia who have failed lifestyle interventions.
- Patients requiring a hypnotic with a lower risk of abrupt withdrawal compared with benzodiazepines.
- Individuals who prefer a once‑nightly oral tablet over multiple dosing regimens.
Clinical scenarios where eszopiclone is particularly recommended:
- Persistent sleep latency > 30 minutes despite sleep‑hygiene optimisation.
- Fragmented sleep with ≥3 awakenings per night.
Contra‑indications and cautions:
- Severe hepatic impairment (Child‑Pugh class C) – reduced clearance may lead to accumulation.
- History of complex sleep‑related behaviours (e.g., sleepwalking, sleep‑driving).
- Concomitant use of strong CYP3A4 inhibitors (ketoconazole, clarithromycin) – dose adjustment may be needed.
Risks, Side Effects, and Interactions
Common
- Taste disturbance (metallic or bitter).
- Daytime drowsiness (especially with higher doses or in the elderly).
- Dry mouth.
- Headache.
Rare
- Complex sleep behaviours such as sleep‑walking, sleep‑driving, or engaging in activities while not fully awake.
- Allergic reactions (rash, pruritus, urticaria).
- Memory impairment or confusion, primarily in older adults.
Serious
- Respiratory depression when combined with central nervous system depressants (opioids, alcohol, benzodiazepines).
- Severe hepatic injury – rare but reported in patients with existing liver disease.
- Psychiatric symptoms (agitation, aggression, hallucinations) in vulnerable individuals.
Clinically Relevant Drug–Drug Interactions
- CYP3A4 inhibitors (ketoconazole, itraconazole, clarithromycin) → increase eszopiclone plasma concentrations; consider dose reduction.
- CYP3A4 inducers (rifampicin, carbamazepine, phenytoin) → decrease exposure; therapeutic effect may be reduced.
- Alcohol or other CNS depressants → additive sedation; avoid concomitant use.
- Anticoagulants – no direct interaction, but caution is advised in patients with impaired hepatic function.
Patients should disclose all current medications, including over‑the‑counter products and herbal supplements, to their prescriber before initiating eszopiclone.
Practical Use: Dosing, Missed Dose, Overdose
Standard dosing (adult, non‑elderly, without hepatic impairment):
- Initiate with 1 mg taken immediately before bedtime, with a full night (7–8 hours) of sleep opportunity.
- If insufficient response after 2–4 weeks, dose may be increased to 2 mg.
- For elderly patients (≥65 years) or those with moderate hepatic impairment, start at 1 mg and maintain; avoid exceeding this dose.
Missed dose:
- If a dose is forgotten and the intended bedtime is still ≥2 hours away, take the missed dose.
- If bedtime is imminent, skip the missed dose and resume the regular schedule the next night. Taking a dose too early may cause next‑day sedation.
Overdose management:
- Signs of overdose include excessive drowsiness, respiratory depression, and confusion.
- Immediate medical attention is required; supportive care (airway management, monitoring of vital signs) is the primary treatment.
- No specific antidote exists; activated charcoal may be considered if presentation is within one hour of ingestion.
Practical precautions:
- Take eszopiclone with a small amount of water; food does not markedly affect absorption.
- Avoid alcohol, sedating antihistamines, and other hypnotics while using eszopiclone.
- Ensure a safe sleep environment—remove hazardous objects and avoid operating machinery after dosing.
Buying Eszopiclone from Our Online Pharmacy
Eszopiclone can be purchased from our online pharmacy in the UK as a clinically equivalent generic product. Our service offers several advantages for patients seeking reliable access to sleep‑aid therapy:
- Affordability: Prices are set near the manufacturer’s cost, providing a substantial saving compared with brand‑name imports.
- Verified quality: All tablets are sourced from GMP‑certified overseas pharmacies that adhere to stringent European quality standards.
- Guaranteed delivery: Orders are dispatched discreetly and can be received within 7 days via express courier or approximately 3 weeks using regular airmail.
- Online‑only access: The platform enables acquisition of international medications without the need for local pharmacy stock, a useful option for patients with limited pharmacy access or restrictive insurance formularies.
Our pharmacy operates as a broker service, partnering with licensed overseas suppliers. This model ensures a discreet, privacy‑focused experience while maintaining regulatory compliance for personal importation of prescription‑only medicines.
FAQ
-
Is Eszopiclone available in both brand‑name and generic forms in the UK?
Yes. The original brand‑name product, Lunesta, is marketed primarily in the United States. In the UK, eszopiclone is supplied as a generic tablet that contains the same active ingredient, offering a more affordable alternative. -
Does eszopiclone require refrigeration or special storage conditions?
No. Eszopiclone tablets should be stored at controlled room temperature, ideally between 15 °C and 30 °C. They must be kept away from direct sunlight, excess heat, and moisture to preserve potency. -
What does the packaging of eszopiclone tablets look like when ordered online?
Tablets are typically packed in sealed blister packs, each blister containing a single tablet. The outer box displays the generic product name, strength (1 mg or 2 mg), batch number, and expiry date, along with the supplier’s licensing information. -
Can eszopiclone be safely imported into the UK for personal use?
Personal importation of a single patient’s supply is permitted under UK regulations, provided the medication is for a legitimate medical purpose and the quantity does not exceed a three‑month supply. Importing through a reputable online pharmacy that complies with the Medicines and Healthcare products Regulatory Agency (MHRA) guidelines helps ensure safety. -
Are there specific warnings for eszopiclone in individuals of Asian descent?
Clinical data indicate that certain Asian populations may experience higher plasma concentrations due to genetic variations in CYP3A4 activity. Consequently, clinicians often recommend starting at the lower 1 mg dose and monitoring for excessive sedation. -
Does the formulation of eszopiclone differ between regions such as the US, EU, and Asia?
The active ingredient remains consistent worldwide, but excipients may vary. For example, some EU‑approved generics use lactose as a filler, whereas certain Asian formulations may employ microcrystalline cellulose. These differences are generally inert but can affect patients with specific allergies or intolerances. -
How long can eszopiclone tablets be kept before they expire?
Most tablets have a shelf life of two to three years from the date of manufacture, as indicated on the packaging. Patients should not use tablets past the printed expiry date to avoid reduced efficacy or potential degradation. -
What is the recommended interval between taking eszopiclone and drinking alcohol?
Alcohol potently enhances the central nervous system depressant effects of eszopiclone and should be avoided entirely on nights when the medication is taken. Combining the two can lead to profound sedation, respiratory depression, and complex sleep behaviours. -
Is there a difference in onset of sleep between the 1 mg and 2 mg doses?
Both doses achieve a similar onset of action (approximately 30–45 minutes). The higher 2 mg dose primarily prolongs sleep maintenance rather than speeding sleep onset, making it useful for patients who awaken frequently during the night. -
Can eszopiclone be taken by people with mild renal impairment?
Since eszopiclone is eliminated primarily via the kidneys, mild renal impairment (creatinine clearance > 50 mL/min) generally does not require dose adjustment. However, in moderate to severe renal dysfunction, clinicians may opt for the lower 1 mg dose and monitor for accumulation.
Glossary
- GABA‑A receptor
- A ligand‑gated ion channel in the central nervous system that, when activated by the neurotransmitter GABA, allows chloride ions to enter the neuron, producing an inhibitory effect that reduces neuronal excitability.
- Half‑life
- The time required for the plasma concentration of a drug to decrease by 50 %. For eszopiclone, the average half‑life is about 6 hours in healthy adults.
- CYP3A4
- An enzyme of the cytochrome P450 family responsible for the metabolism of many drugs, including eszopiclone. Inhibitors or inducers of CYP3A4 can respectively increase or decrease the drug’s plasma levels.
- Complex sleep behaviours
- Unusual activities performed while partially asleep, such as sleep‑walking, sleep‑driving, or cooking, that can pose safety risks. These behaviours are rare but documented with hypnotic agents that influence the central nervous system.
⚠️ Disclaimer
The information provided about Eszopiclone is for general knowledge only. It does not replace professional medical consultation. All treatment decisions should be made under the supervision of a qualified healthcare provider. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to Eszopiclone for individuals who may have limited availability through traditional pharmacies, prescription‑based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.